|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―May―14 |
In silico evidence that substitution of glycine for valine (p.G8V) in a common variant of TMPRSS2 isoform 1 increases accessibility to an endocytic signal: implication for SARS-CoV-2 entry into host cells and susceptibility to COVID-19 |
Matteo Calcagnile, Fabrizio Damiano, Giambattista Lobreglio, Luisa Siculella, Maria Pia Bozzetti, Patricia Forgez, et al. (+5) Alexandra Malgoyre, Nicolas Libert, Cecilia Bucci, Marco Alifano, Pietro Alifano |
2 |
[GO] |
2024―May―03 |
Myelin basic protein antagonizes the SARS-CoV-2 protein ORF3a-induced autophagy inhibition |
George A. Saratov, Alexey A. Belogurov, Anna A. Kudriaeva |
3 |
[GO] |
2024―Mar―01 |
Cytoskeletal β-tubulin and cysteine cathepsin L deregulation by SARS-CoV-2 spike protein interaction with the neuronal model cell line SH-SY5Y |
Bernardo R. Oliveira, Inga Nehlmeier, Amy Madeleine Kempf, Vaishnavi Venugopalan, Maren Rehders, Marianne E.P. Ceniza, et al. (+4) Pedro A.de T.P.V. Cavalcanti, Markus Hoffmann, Stefan Pöhlmann, Klaudia Brix |
4 |
[GO] |
2023―May―23 |
Possible cancer-causing capacity of COVID-19: Is SARS-CoV-2 an oncogenic agent? |
Kasra Jahankhani, Fatemeh Ahangari, Ian M. Adcock, Esmail Mortaz |
5 |
[GO] |
2023―Mar―16 |
At the crossroads of epidemiology and biology: Bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics |
Florian Poydenot, Alice Lebreton, Jacques Haiech, Bruno Andreotti |
6 |
[GO] |
2022―Oct―15 |
Effects of natural polymorphisms in SARS-CoV-2 RNA-dependent RNA polymerase on its activity and sensitivity to inhibitors in vitro |
Nataliya Miropolskaya, Maxim Kozlov, Ivan Petushkov, Maria Prostova, Danil Pupov, Daria Esyunina, et al. (+2) Sergey Kochetkov, Andrey Kulbachinskiy |
7 |
[GO] |
2022―Aug―09 |
Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19 |
Aurélien Philippe, Mathilde Puel, Céline Narjoz, Nicolas Gendron, Marie Agnès Durey-Dragon, Benoit Vedie, et al. (+8) Malika Balduyck, Richard Chocron, Caroline Hauw-Berlemont, Olivier Sanchez, Tristan Mirault, Jean-Luc Diehl, David M. Smadja, Marie Anne Loriot |
8 |
[GO] |
2022―Jun―17 |
Early shedding of membrane-bounded ACE2 could be an indicator for disease severity in SARS-CoV-2 |
Vignesh Mariappan, Pajanivel Ranganadin, Lokesh Shanmugam, S.R. Rao, Agieshkumar Balakrishna Pillai |
9 |
[GO] |
2022―May―26 |
Binding of SARS-CoV-2 protein ORF9b to mitochondrial translocase TOM70 prevents its interaction with chaperone HSP90 |
Kehinde S. Ayinde, Glaucia M.S. Pinheiro, Carlos H.I. Ramos |
10 |
[GO] |
2022―Jan―26 |
The enzymes in COVID-19: A review |
Maria Helena Menezes Estevam Alves, Layla Carvalho Mahnke, Tifany Cerqueira Macedo, Thais Ketinly dos Santos Silva, Luiz Bezerra de Carvalho Junior |
11 |
[GO] |
2021―Nov―15 |
SARS-CoV-2 may affect the immune response via direct inhibition of T cell receptor: Mechanistic hypothesis and rationale |
Alexander B. Sigalov |
12 |
[GO] |
2021―Oct―25 |
Unravelling the molecular interactions between the SARS-CoV-2 RBD spike protein and various specific monoclonal antibodies |
Didac Martí, Marc Alsina, Carlos Alemán, Oscar Bertran, Pau Turon, Juan Torras |
13 |
[GO] |
2021―Sep―21 |
On the footsteps of Hippocrates, Sanctorius and Harvey to better understand the influence of cold on the occurrence of COVID-19 in European countries in 2020 |
Philippe Icard, Luca Simula, Joana Rei, Ludovic Fournel, Vincent DE. Pauw, Marco Alifano |
14 |
[GO] |
2021―Sep―08 |
Dynamics prediction of emerging notable spike protein mutations in SARS-CoV-2 implies a need for updated vaccines |
Walid Al-Zyoud, Hazem Haddad |
15 |
[GO] |
2021―Jun―18 |
Coronaviruses, cholesterol and statins: Involvement and application for Covid-19 |
Stéphane Orlowski, Jean-Jacques Mourad, Antonio Gallo, Eric Bruckert |
16 |
[GO] |
2021―Jun―16 |
What do secreted phospholipases A2 have to offer in combat against different viruses up to SARS-CoV-2? |
Jože Pungerčar, Franck Bihl, Gérard Lambeau, Igor Križaj |
17 |
[GO] |
2021―May―31 |
Essential sufficiency of zinc, ω-3 polyunsaturated fatty acids, vitamin D and magnesium for prevention and treatment of COVID-19, diabetes, cardiovascular diseases, lung diseases and cancer |
Michael J. Story |
18 |
[GO] |
2021―May―11 |
Molecular simulation studies of the interactions between the human/pangolin/cat/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein |
Shaojie Ma, Hui Li, Jun Yang, Kunqian Yu |
19 |
[GO] |
2021―Feb―25 |
SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators |
Mayssa Hachem |
20 |
[GO] |
2021―Jan―20 |
Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2 |
Mira A.M. Behnam |
21 |
[GO] |
2020―Nov―12 |
The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response |
Philippe Icard, Hubert Lincet, Zherui Wu, Antoine Coquerel, Patricia Forgez, Marco Alifano, Ludovic Fournel |
22 |
[GO] |
2020―Nov―09 |
Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein |
Matteo Calcagnile, Patricia Forgez, Antonio Iannelli, Cecilia Bucci, Marco Alifano, Pietro Alifano |
23 |
[GO] |
2020―Nov―06 |
Special Section Involvement of lipids in the occurrence of COVID-19 |
Vincent Rioux, Michel Record |
24 |
[GO] |
2020―Nov―05 |
Bis(monoacylglycero)phosphate, an important actor in the host endocytic machinery hijacked by SARS-CoV-2 and related viruses |
Céline Luquain-Costaz, Maxence Rabia, Françoise Hullin-Matsuda, Isabelle Delton |
25 |
[GO] |
2020―Oct―25 |
Membrane heist: Coronavirus host membrane remodeling during replication |
Jingshu Zhang, Yun Lan, Sumana Sanyal |
26 |
[GO] |
2020―Sep―22 |
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2 |
Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran, Uma Maheswari Krishnan |
27 |
[GO] |
2020―Sep―10 |
May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients? |
Pierre Weill, Claire Plissonneau, Philippe Legrand, Vincent Rioux, Ronan Thibault |
28 |
[GO] |
2020―Sep―03 |
Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury? |
Pierre-Jean Ferron, Thomas Gicquel, Bruno Mégarbane, Bruno Clément, Bernard Fromenty |
29 |
[GO] |
2020―Aug―14 |
Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon? |
Razieh Dowran, Seyed Fazel Nabavi, Solomon Habtemariam, Maciej Banach, Shiva Shahmohamadnejad, Cosmin Andrei Cismaru, et al. (+3) Ioana Berindan-Neagoe, Adeleh Sahebnasagh, Seyed Mohammad Nabavi |
30 |
[GO] |
2020―Jul―08 |
High prevalence for obesity in severe COVID-19: Possible links and perspectives towards patient stratification |
Isabelle Dugail, Ez-Zoubir Amri, Nicolas Vitale |
31 |
[GO] |
2020―May―30 |
The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway |
Frédéric Carrière, Sonia Longhi, Michel Record |
32 |
[GO] |
2020―May―29 |
SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention |
Ismail Sami Mahmoud, Yazun Bashir Jarrar, Walhan Alshaer, Said Ismail |
33 |
[GO] |
2020―Apr―16 |
Renin-angiotensin system at the heart of COVID-19 pandemic |
Marco Alifano, Pietro Alifano, Patricia Forgez, Antonio Iannelli |